Multiple distant metastases in a case of malignant pleural mesothelioma  by Tertemiz, Kemal Can et al.
lable at ScienceDirect
Respiratory Medicine Case Reports 13 (2014) 16e18Contents lists avaiRespiratory Medicine Case Reports
journal homepage: www.elsevier .com/locate /rmcrCase reportMultiple distant metastases in a case of malignant pleural
mesothelioma
Kemal Can Tertemiz a, *, Aylin Ozgen Alpaydin a, Duygu Gurel b, Recep Savas c,
Aytac Gulcu d, Atila Akkoclu a
a Pulmonary Diseases, Dokuz Eylul University Medical Faculty, Izmir, Turkey
b Pathology, Dokuz Eylul University Medical Faculty, Izmir, Turkey
c Nuclear Medicine, Dokuz Eylul University Medical Faculty, Izmir, Turkey
d Radiology, Dokuz Eylul University Medical Faculty, Izmir, TurkeyKeywords:
Malignant pleural mesothelioma
Metastases
PET-CT* Corresponding author. Dokuz Eylul University
Medicine, Balcova, Izmir 35340, Turkey.
E-mail addresses: tkemalcan@yahoo.com (K.C. Ter
tr (A. Ozgen Alpaydin), duygu.gurel@deu.edu.tr (D
(R. Savas), aytac.gulcu@deu.edu.tr (A. Gulcu
(A. Akkoclu).
http://dx.doi.org/10.1016/j.rmcr.2014.07.003
2213-0071/© 2014 The Authors. Published by Elseviera b s t r a c t
Introduction: Malignant pleural mesothelioma (MPM) is a malignant of mesodermal neoplasm and arises
from multipotential mesothelial or subserosal cells of the pleura, pericardium and peritoneum.
Case: A seventy ﬁve year-old male patient was admitted with chest and lower limb pain. He was a heavy
smoker and exposed to environmental asbestos in his childhood. PET-CT scans showed multiple path-
ological FDG uptakes in lungs and other organs. Biopsies performed from lung and anterior thigh muscles
were reported as epitheloid type malignant pleural mesothelioma.
Discussion: We emphasize that unexpected distant metastases can be observed in MPM and occasionally
primary diagnosis can be determined by the biopsy of the metastatic regions. This case also points out
the role of PET-CT in the staging of malign mesothelioma by determining different metastatic sites.
© 2014 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-SA
license (http://creativecommons.org/licenses/by-nc-sa/3.0/).Introduction
Malignant pleural mesothelioma (MPM) is a malignant of
mesodermal neoplasm and arises from multipotential mesothelial
or subserosal cells of the pleura, pericardium and peritoneum.
Three different pathological forms are deﬁned: epitheloid (60%),
sarcomatoid (10e20%) and biphasic patterns (20e30%) [1].
MPM is a rare tumor, however the incidence is increasing and
the mortality is high. MPM behaves aggressively and complete re-
sponses to currently available treatment are occasionally observed.
A median progression free survival is 6 months, while overall sur-
vival is 12 months, with a reported rate of 30e40%, response rates
[2e4].
Generally, metastatic disease is not depicted at the time of initial
diagnosis. Major sites for metastases are regional lymph nodes,
lung, liver, adrenal glands, and kidneys [5]. In a postmortem study
extrapleural dissemination was found in 87.7% of cases. TumorMedical Faculty, Pulmonary
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(10.8%), thyroid (6.9%), and the brain (3.0%) [6].
Distant metastases of MPM to the multiple skeletal muscle,
endocardium and skin together have not been reported before. We
present an epiteloid type MPM case with distant metastases to
skeletal muscles (pathologically conﬁrmed), endocardium and
subcutaneous tissue.Case
A seventy ﬁve year-old male patient admitted to our pulmonary
diseases clinic with chest and lower limb pain. He was a heavy
smoker and exposed to environmental asbestos in his childhood.
His medical history was otherwise unremarkable. In physical ex-
amination respiratory system was normal. The thigh muscles were
observed to be thick, hard and palpation was painful. There were
few nodular lesions on the scalp which he reported to appear 2
months ago as well as the femoral thickening accompanying.
In his routine blood and biochemistry tests sedimentation rate
was 61 mm/h, potassium 5, 3 was mMol/L, C reactive protein was
169 mg/L and other ﬁndings were normal. Chest X-ray showed
upper mediastinal enlargement and a mass in left upper zone
(Fig. 1). In his thorax CT a 5 cm scale pleural mass in the left
mediastinal and lateral pleural region, left hilar 2 cm scalender the CC BY-NC-SA license (http://creativecommons.org/licenses/by-nc-sa/3.0/).
Fig. 1. Chest X-ray.
Fig. 3. PET-CT scan of legs.
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monary nodule in right lung and right pleural calciﬁcation were
seen.
In his PET-CT; pathological FDG uptakes were seen in the
localization of ligamenthum nuchea (C2e3 level), right paraspinalFig. 2. PET scan of whole body.muscle (C6), posterior scalp, paratracheal and left hilar lymph
nodes, left apical mass, left pleura in lower and middle zone, left
diaphragma, anterior pericardium, interventricular septum, left
axilla, right 4. costochondral region, liver segment 8, right para-
spinal muscle in L3 level, right abdominal obliquemuscles, bilateral
gluteal muscles and bilateral thigh muscles (Figs. 2e4).
Tru-cut biopsy was performed from the left apical mass. And
epitheloid type malignant pleural mesothelioma was the diagnose
(Fig. 5). Another biopsy performed from anterior thighmuscles. The
pathological pattern was the same with the biopsy taken from
lungs (Fig. 6).Discussion
Most (>90%) mesothelioma cases are pleura originated, and it is
generally perceived as a locally aggressive cancer [6]. Despite
currently available systemic chemotherapy, long term survival in
patients with MPM is poor. MPM is a kind of preterminal condition
with an expected life expectancy of less than 12 months [7].
Currently, the major modality for tumor staging has become
PET-CT. The utility of PET-CT in malignant pleural mesothelioma is
contraversial; however, malignant pleural mesothelioma is clearly
FDG avid, and PET may help in staging as well as giving prognostic
information [8,9]. PET-CT sensitivity and speciﬁcity for pleural le-
sions are 90e95% and 75e80% respectively [10]. In this case PET-CT
scans showed us multiple distant pathological FDG uptakes in
paraspinal muscles, posterior scalp, rib, interventricular septum,
liver, right abdominal oblic muscles, bilateral gluteal and thigh
muscles. And also locally invasion was seen in lymph nodes, dia-
phragm and pericardium. So PET-CT should be realized for all MPM
patients for staging and detecting asymptomatic distantmetastasis.Fig. 4. PET-CT scan of pelvic region.
Fig. 5. Lung: Neoplastic cells positive staining with calretinin.
Fig. 6. Muscle byopsy:positivite staining with CK5/6.
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value was observed 9.4 in thigh muscles. Calretinin and cytoker-
atins 5/6 are important immunohistochemical mesothelial markers
substantiating diagnosis for an epitheloid mesothelioma [1]. In that
case these markers found strongly positive in tumor cells on
immunohistochemical staining. Transthoracic biopsy taken from
the left lung revealed epitheloid type malignant pleural mesothe-
lioma, and the biopsy taken from thigh muscles was also concor-
dant with epitheloid type malignant mesothelioma.
Distant metastasis of a malignant mesothelioma is uncommon
[5]. Previous studies have reported conﬂicting results on themetastatic behavior of MPM subtypes. And pleomorphic epithelioid
mesothelioma that appears to have distinct clinical characteristics
[6]. Regional lymph nodes are the major metastatic sites of MPM
which have been reported in 40% of the cases [10]. Skeletal muscle
metastasis was described in only one case and subcutaneous nod-
ules in few cases before [11e13].
We presented this patient for the interestingness due to unusual
and previously undeﬁned diffuse metastasis of malign mesotheli-
oma. We emphasize that unexpected distant metastases can be
seen in MPM and occasionally primary diagnosis can be made by
the biopsy of the metastatic regions. This case also points out the
role of PET-CT in the staging of malign mesothelioma by deter-
mining different metastatic sites.
Note: The patient is alive up to day (14 months after diagnosis)
with cisplatin and pemetrexed therapy.References
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